Machine learning for modeling the progression of Alzheimer disease dementia using clinical data: a systematic literature review
Open Access
- 1 July 2021
- journal article
- review article
- Published by Oxford University Press (OUP) in JAMIA Open
- Vol. 4 (3) , ooab052
Abstract
Objective: Alzheimer disease (AD) is the most common cause of dementia, a syndrome characterized by cognitive impairment severe enough to interfere with activities of daily life. We aimed to conduct a systematic literature review (SLR) of studies that applied machine learning (ML) methods to clinical data derived from electronic health records in order to model risk for progression of AD dementia. Materials and Methods: We searched for articles published between January 1, 2010, and May 31, 2020, in PubMed, Scopus, ScienceDirect, IEEE Explore Digital Library, Association for Computing Machinery Digital Library, and arXiv. We used predefined criteria to select relevant articles and summarized them according to key components of ML analysis such as data characteristics, computational algorithms, and research focus. Results: There has been a considerable rise over the past 5 years in the number of research papers using ML-based analysis for AD dementia modeling. We reviewed 64 relevant articles in our SLR. The results suggest that majority of existing research has focused on predicting progression of AD dementia using publicly available datasets containing both neuroimaging and clinical data (neurobehavioral status exam scores, patient demographics, neuroimaging data, and laboratory test values). Discussion: Identifying individuals at risk for progression of AD dementia could potentially help to personalize disease management to plan future care. Clinical data consisting of both structured data tables and clinical notes can be effectively used in ML-based approaches to model risk for AD dementia progression. Data sharing and reproducibility of results can enhance the impact, adaptation, and generalizability of this research.Keywords
All Related Versions
Funding Information
- Centene Corporation (P19-00559)
- Washington University-Centene ARCH Personalized Medicine Initiative (K23AG053426)
This publication has 78 references indexed in Scilit:
- MIMIC-III, a freely accessible critical care databaseScientific Data, 2016
- The FAIR Guiding Principles for scientific data management and stewardshipScientific Data, 2016
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteriaAlzheimer's & Dementia, 2016
- Modeling Disease Progression via Multisource Multitask Learners: A Case Study With Alzheimer’s DiseaseIEEE Transactions on Neural Networks and Learning Systems, 2016
- Temporal Trajectory and Progression Score Estimation from Voxelwise Longitudinal Imaging Measures: Application to Amyloid Imaging2015
- Methods and considerations for longitudinal structural brain imaging analysis across developmentDevelopmental Cognitive Neuroscience, 2014
- The A4 Study: Stopping AD Before Symptoms Begin?Science Translational Medicine, 2014
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort studyThe Lancet Neurology, 2013
- Alzheimer's diseaseThe Lancet, 2011
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005